Clinical Research Fellow at Queen Mary University of London

HomeHealth & Fitness

Clinical Research Fellow at Queen Mary University of London

my-portfolio

[ad_1] About the Role The role of the Rheumatology Clinical Research Fellow is to provide medical support for the portfolio of commerc

Senior Project Manager – Malaria Vaccine Programme at University of Oxford
Clinical Research Fellow in Translational GI Oncology at Queen Mary University of London
Development of an Electrospun Antimicrobial Coated Tampon for Management of Bacterial Vaginosis Biofilm at University of Bradford

[ad_1]

About the Role

The role of the Rheumatology Clinical Research Fellow is to provide medical support for the portfolio of commercial and academic rheumatology research studies, including regulated clinical trials (CTIMPs), being undertaken at Mile End Hospital. The post-holder will aid in the identification and recruitment of patients and will perform trial visits and assessments as per trial protocols. The post-holder will also have the opportunity to learn MSK ultrasound techniques and train in performing ultrasound guided synovial biopsies.

This is an outstanding opportunity to gain experience working in one of the leading centres worldwide in biopsy-driven clinical trials in rheumatoid arthritis (RA). It will provide training in clinical trials and translational medicine as well as more general rheumatology training. It would suit someone who wishes to gain experience in clinical trials, and/or an individual considering a career in rheumatology wishing to obtain more exposure to the specialty in an exciting and stimulating academic environment, with the opportunity to develop research skills and clinical experience in rheumatology.

About the Centre of Experimental Medicine & Rheumatology (EMR)

EMR opened in May 2007 and is led by Professor Costantino Pitzalis. The Centre is focused on the development of innovative therapeutic and diagnostic approaches to inflammatory and degenerative arthropathies, particularly rheumatoid and osteo arthritis.

The Centre is linked to the NIHR Barts Biomedical Research Centre which was successfully awarded £28 million in funding in 2022. It is one of the leading centres worldwide in biopsy-driven clinical trials in RA, having in recent years completed two of the first stratified, biopsy-driven, multicentre, randomised controlled trials in RA; R4RA, the results of which were published in The Lancet and Nature Medicine, and the STRAP trial (pending publication). Mile End Hospital is also the primary recruiter to the PEAC/PEsAC Study, which has provided an extensively phenotyped cohort of patients with inflammatory arthritis linked to detailed pathobiological data since 2008, paving the road for precision medicine trials in inflammatory arthritis. More information can be found on our website here.

About Queen Mary

At QMUL, we believe that a diversity of ideas helps us achieve the previously unthinkable. Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers. We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.

Benefits

We offer competitive salaries, access to a generous pension scheme, 30 days’ leave p/a, a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities.

The post is full time, fixed appointment for 12 months. The salary will be in the range of £34,012-£51,017 p/a, depending on experience & current grading.

Informal enquiries should be sent to Dr Alessandra Nerviani alessandra.nerviani@nhs.net

For further details please see the attached job pack.

The closing date for applications is 18 June 2023. Interviews are expected to be held shortly thereafter.

[ad_2]

Source link

COMMENTS

WORDPRESS: 0
DISQUS: